FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

ULTRAtab Laboratories Pain Aid Esf- Recall

PAIN AID ESF- (Acetaminopehn USP 250mg, Asprin USP 250mg Caffeine 65mg) coated, bulk OT…

ULTRAtab Laboratories, Inc. · Highland, NY

Risk level
Class II
Reported by FDA
Jan 12, 2022
Recall ID
D-0327-2022
Check your lot numberHow we source this data

Summary

ULTRAtab Laboratories recalled Pain Aid Esf- starting Nov 29, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0327-2022 on Jan 12, 2022. Reason: CGMP Deviations: failed stability results, inadequate laboratory investigations,. Status: Terminated.

Why it was recalled

CGMP Deviations: failed stability results, inadequate laboratory investigations,

Product description

PAIN AID ESF- (Acetaminopehn USP 250mg, Asprin USP 250mg Caffeine 65mg) coated, bulk OTC tablets packaged in corrugated boxes lined with 2 polyethylene bags 100 lb, ULTRAtab Laboratories, Inc. NDC# 62959-560-00, Product Code M560L

Lot numbers, UPCs & expiration codes

Bulk Lots: 18K070, exp. date Nov-21; 19A046, exp. date Jan-22; 19C073, exp. date Mar-22; 19E014, exp. date May-22; 19G039, exp. date Jul-22; 19K002, exp. date Nov-22; 20A013, exp. date Jan-23; 20B050, exp. date Feb-23; 20C011, exp. date Mar-23; 20C049, exp. date Mar-23; 20F071, exp. date Jun-23; 20F072, exp. date Jun-23; 20G033, exp. date Jul-23; 20G041, exp. date Jul-23.

Where it was sold

Product was distributed to one customer who may have further distributed the product.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0327-2022
Classification
Class II
Status
Terminated
Recall initiated
Nov 29, 2021
FDA report date
Jan 12, 2022
Quantity
14 bulk lots (approximately 1,987,951 tablets each)
Recall type
Voluntary: Firm initiated
Recalling firm
ULTRAtab Laboratories, Inc.

Original FDA data

Every field from FDA enforcement report D-0327-2022, exactly as published.

Show all FDA fields
City
Highland
State
NY
Status
Terminated
Country
United States
Event ID
89214
Address
50 Toc Dr
Code information
Bulk Lots: 18K070, exp. date Nov-21; 19A046, exp. date Jan-22; 19C073, exp. date Mar-22; 19E014, exp. date May-22; 19G039, exp. date Jul-22; 19K002, exp. date Nov-22; 20A013, exp. date Jan-23; 20B050, exp. date Feb-23; 20C011, exp. date Mar-23; 20C049, exp. date Mar-23; 20F071, exp. date Jun-23; 20F072, exp. date Jun-23; 20G033, exp. date Jul-23; 20G041, exp. date Jul-23.
Postal code
12528-1506
Report date
Jan 12, 2022
Product type
Drugs
Recall number
D-0327-2022
Classification
Class II
Recalling firm
ULTRAtab Laboratories, Inc.
Product quantity
14 bulk lots (approximately 1,987,951 tablets each)
Termination date
Feb 24, 2023
Reason for recall
CGMP Deviations: failed stability results, inadequate laboratory investigations,
Voluntary / mandated
Voluntary: Firm initiated
Product description
PAIN AID ESF- (Acetaminopehn USP 250mg, Asprin USP 250mg Caffeine 65mg) coated, bulk OTC tablets packaged in corrugated boxes lined with 2 polyethylene bags 100 lb, ULTRAtab Laboratories, Inc. NDC# 62959-560-00, Product Code M560L
Distribution pattern
Product was distributed to one customer who may have further distributed the product.
Recall initiation date
Nov 29, 2021
Initial firm notification
Letter
Center classification date
Jan 4, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0327-2022, published Jan 12, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls